Glykit-MV 1 Tablet SR
Marketer
Forschung India
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glykit-MV 1 Tablet SR
Diabetol-Duo, a single-strength extended-release tablet, is an antidiabetic medication combining two active components for managing type 2 diabetes in adults. It effectively regulates blood glucose. Diabetol-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision loss, neuropathy, and limb issues. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, edema (swelling), blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.
Uses of Glykit-MV 1 Tablet SR
Managing Type 2 diabetes
Major Benefits of Glykit-MV 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Administer Glykit-MV 1 Tablet SR on an empty stomach.
Common Side effects of Glykit-MV 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glykit-MV 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glykit-MV 1 Tablet SR should be taken on an empty stomach.
How Glykit-MV 1 Tablet SR works:
One Glykit-MV SR tablet combines three distinct anti-diabetic medications.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Glykit-MV 1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glykit-MV 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glykit-MV tablet (1 mg) likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly causing infant harm.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Glykit-MV 1 Tablet SR is likely inadvisable for individuals with kidney impairment and should be eschewed. Physician consultation is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glykit-MV 1 Tablet SR cautiously, potentially requiring dose modification. Consult your physician. For those with mild to moderate liver disease, initiation should be at a low dose; however, Glykit-MV 1 Tablet SR is contraindicated in severe liver disease.
What if you forget to take Glykit-MV 1 Tablet SR :
Should you forget to take a Glykit-MV 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glykit-MV 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


